Evidence map›Paper›PMID 31405953›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Harry Petrushkin, Paul J Norman, Emma Lougee, Peter Parham, Graham R Wallace, Miles R Stanford, Farida Fortune

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Behçet's Disease: A Comprehensive Review on the Role ofInternational journal of molecular sciences · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Darwinian View of Behçet's Disease.Rheumatology and immunology research · 2021
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Harry PetrushkinMoorfields Eye Hospital National Health Service Foundation Trust, Medical Retina Department, London EC1V 2PD, United Kingdom.
Paul J NormanDivision of Biomedical Informatics and Personalized Medicine, Department of Microbiology and Immunology, University of Colorado, Aurora, CO 80045.ORCID 0000-0001-8370-7703
Emma LougeeViapath, Clinical Transplantation Laboratory, Guy's Hospital, Guy's and St Thomas' National Health Service Foundation Trust, London SE1 9RT, United Kingdom.
Peter ParhamDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305.
Graham R WallaceCentre for Translational Inflammation Research, University of Birmingham Research Laboratories, Queen Elizabeth Hospital, University of Birmingham, Birmingham B15 2TT, United Kingdom; and.ORCID 0000-0003-2054-0509
Miles R StanfordMedical Eye Unit, St Thomas' Hospital, Guy's and St Thomas' National Health Service Foundation Trust, London SE1 7EH, United Kingdom.
Farida FortuneClinical and Diagnostic Oral Sciences, Queen Mary University of London, Blizard Institute, E1 2AT London, United Kingdom; f.fortune@qmul.ac.uk.ORCID 0000-0001-5930-1973
National Health Service · GBQueen Elizabeth Hospital Birmingham · GBQueen Mary University of London · GBStanford University · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Insights Into Immune-Related Diseases Born from Population GenomicsU01AI090905 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Paul John Norman · 2010 to 2026
$10.9M
NIAID NIH HHS U01 AI090905
6 · The paper itself

Abstract

Behçet disease is a chronic, relapsing-remitting autoinflammatory syndrome with a strong

Indexed as

AdultAllelesBehcet SyndromeCase-Control StudiesCohort StudiesFemaleGene FrequencyGenotypeHLA-B AntigensHumansMaleMiddle AgedReceptors, KIR3DL1HLA-B AntigensKIR3DL1 protein, humanReceptors, KIR3DL1

Identifiers

PMID31405953
PMCPMC6731450
OpenAlexW2968856281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.